<?xml version="1.0" encoding="UTF-8"?>
<table-wrap id="tbl28482" orientation="portrait" position="float">
 <label>Table 1.</label>
 <caption>
  <title> Basic Characteristics of the Included Studies 
   <sup>
    <xref ref-type="table-fn" rid="fn27897">a</xref>
   </sup>
  </title>
 </caption>
 <table frame="hsides" rules="groups">
  <thead>
   <tr>
    <th style="text-align: left;vertical-align: top;" rowspan="1" colspan="1">Included Studies</th>
    <th style="border-bottom: solid thin;" colspan="2" rowspan="1">Cases</th>
    <th style="border-bottom: solid thin;" colspan="2" rowspan="1">Intervening Measures</th>
    <th style="vertical-align: top;" rowspan="1" colspan="1">Course of Treatment</th>
    <th style="vertical-align: top;" rowspan="1" colspan="1">Efficacy of Indicators</th>
   </tr>
   <tr>
    <th style="text-align: left;" rowspan="1" colspan="1"/>
    <th style="vertical-align: top;" rowspan="1" colspan="1">Experimental Group</th>
    <th style="vertical-align: top;" rowspan="1" colspan="1">Control Group</th>
    <th style="vertical-align: top;" rowspan="1" colspan="1">Experimental Group</th>
    <th style="vertical-align: top;" rowspan="1" colspan="1">Control Group</th>
    <th rowspan="1" colspan="1"/>
    <th rowspan="1" colspan="1"/>
   </tr>
  </thead>
  <tbody>
   <tr style="vertical-align: top;">
    <td rowspan="1" colspan="1">
     <bold>Xia et al. (</bold>
     <xref rid="A29052R20" ref-type="bibr">20</xref>
     <bold>)</bold>
    </td>
    <td style="text-align: center;" rowspan="1" colspan="1">58</td>
    <td style="text-align: center;" rowspan="1" colspan="1">57</td>
    <td style="text-align: center;" rowspan="1" colspan="1">NAC (8 g/d) + basic treatment</td>
    <td style="text-align: center;" rowspan="1" colspan="1">Basic treatment (Potassium magnesium aspartate 2 g/d + promote the liver cell auxin 0.1 g/d + plasma 200 ml qod + other symptomatic and supportive treatments)</td>
    <td style="text-align: center;" rowspan="1" colspan="1">30 d</td>
    <td style="text-align: center;" rowspan="1" colspan="1">TBIL</td>
   </tr>
   <tr style="vertical-align: top;">
    <td rowspan="1" colspan="1">
     <bold>Shi et al. (</bold>
     <xref rid="A29052R21" ref-type="bibr">21</xref>
     <bold>)</bold>
    </td>
    <td style="text-align: center;" rowspan="1" colspan="1">20</td>
    <td style="text-align: center;" rowspan="1" colspan="1">20</td>
    <td style="text-align: center;" rowspan="1" colspan="1">NAC (8 g/d) + basic treatment</td>
    <td style="text-align: center;" rowspan="1" colspan="1">Basic treatment (Vitamin K 10 mg/d + promote the liver cell auxin 20 mg/d + plasma 200 ml qod or albumin 10 g qod + ranitidine 150 mg po tid + other symptomatic and supportive treatments)</td>
    <td style="text-align: center;" rowspan="1" colspan="1">45 d</td>
    <td style="text-align: center;" rowspan="1" colspan="1">ALT, AST, TBIL</td>
   </tr>
   <tr style="vertical-align: top;">
    <td rowspan="1" colspan="1">
     <bold>Wang et al. (</bold>
     <xref rid="A29052R19" ref-type="bibr">19</xref>
     <bold>)</bold>
    </td>
    <td style="text-align: center;" rowspan="1" colspan="1">50</td>
    <td style="text-align: center;" rowspan="1" colspan="1">25</td>
    <td style="text-align: center;" rowspan="1" colspan="1">NAC (8 g/d) + GSH (1.2 g/d)</td>
    <td style="text-align: center;" rowspan="1" colspan="1">GSH (1.2 g/d)</td>
    <td style="text-align: center;" rowspan="1" colspan="1">28 d</td>
    <td style="text-align: center;" rowspan="1" colspan="1">ALT, AST, TBIL</td>
   </tr>
   <tr style="vertical-align: top;">
    <td rowspan="1" colspan="1">
     <bold>Shohrati et al. (</bold>
     <xref rid="A29052R22" ref-type="bibr">22</xref>
     <bold>)</bold>
    </td>
    <td style="text-align: center;" rowspan="1" colspan="1">18</td>
    <td style="text-align: center;" rowspan="1" colspan="1">20</td>
    <td style="text-align: center;" rowspan="1" colspan="1">NAC (1.2 g/d) + basic treatment</td>
    <td style="text-align: center;" rowspan="1" colspan="1">Basic treatment (lamivudine + pegylated interferon + adefovir)</td>
    <td style="text-align: center;" rowspan="1" colspan="1">45 d</td>
    <td style="text-align: center;" rowspan="1" colspan="1">ALT, AST, ALP, TBIL</td>
   </tr>
   <tr style="vertical-align: top;">
    <td rowspan="1" colspan="1">
     <bold>Wu et al. (</bold>
     <xref rid="A29052R23" ref-type="bibr">23</xref>
     <bold>)</bold>
    </td>
    <td style="text-align: center;" rowspan="1" colspan="1">72</td>
    <td style="text-align: center;" rowspan="1" colspan="1">72</td>
    <td style="text-align: center;" rowspan="1" colspan="1">NAC(8 g/d) + basic treatment</td>
    <td style="text-align: center;" rowspan="1" colspan="1">Basic treatment (Vitamin K 10 mg/d + promote the liver cell auxin 20 mg/d + plasma 200 ml qod or albumin 10 g qod + ranitidine 150 mg po tid + other symptomatic and supportive treatments)</td>
    <td style="text-align: center;" rowspan="1" colspan="1">45 d</td>
    <td style="text-align: center;" rowspan="1" colspan="1">ALT, AST, TBIL</td>
   </tr>
   <tr style="vertical-align: top;">
    <td rowspan="1" colspan="1">
     <bold>Wang et al. (</bold>
     <xref rid="A29052R24" ref-type="bibr">24</xref>
     <bold>)</bold>
    </td>
    <td style="text-align: center;" rowspan="1" colspan="1">42</td>
    <td style="text-align: center;" rowspan="1" colspan="1">42</td>
    <td style="text-align: center;" rowspan="1" colspan="1">UDCA (0.5 g/d) + GSH (1.2 g/d)</td>
    <td style="text-align: center;" rowspan="1" colspan="1">Yinzhihuang (30 ml/d)</td>
    <td style="text-align: center;" rowspan="1" colspan="1">8 w</td>
    <td style="text-align: center;" rowspan="1" colspan="1">ALT, GGT, ALP, TBIL</td>
   </tr>
   <tr style="vertical-align: top;">
    <td rowspan="1" colspan="1">
     <bold>Fabris et al. (</bold>
     <xref rid="A29052R25" ref-type="bibr">25</xref>
     <bold>)</bold>
    </td>
    <td style="text-align: center;" rowspan="1" colspan="1">40</td>
    <td style="text-align: center;" rowspan="1" colspan="1">39</td>
    <td style="text-align: center;" rowspan="1" colspan="1">UDCA (0.6 g/d) + lactulose (100-200 g/d)</td>
    <td style="text-align: center;" rowspan="1" colspan="1">Lactulose (100 - 200 g/d)</td>
    <td style="text-align: center;" rowspan="1" colspan="1">3 w</td>
    <td style="text-align: center;" rowspan="1" colspan="1">ALT, AST, GGT, ALP, TBIL</td>
   </tr>
   <tr style="vertical-align: top;">
    <td rowspan="1" colspan="1">
     <bold>Angulo et al. (</bold>
     <xref rid="A29052R26" ref-type="bibr">26</xref>
     <bold>)</bold>
    </td>
    <td style="text-align: center;" rowspan="1" colspan="1">21</td>
    <td style="text-align: center;" rowspan="1" colspan="1">16</td>
    <td style="text-align: center;" rowspan="1" colspan="1">UDCA (13 - 15 mg/kg/d)</td>
    <td style="text-align: center;" rowspan="1" colspan="1">D-penicillamine (the dosage was unclear)</td>
    <td style="text-align: center;" rowspan="1" colspan="1">24 w</td>
    <td style="text-align: center;" rowspan="1" colspan="1">AST, TBIL</td>
   </tr>
   <tr style="vertical-align: top;">
    <td rowspan="1" colspan="1">
     <bold>Cao et al. (</bold>
     <xref rid="A29052R27" ref-type="bibr">27</xref>
     <bold>)</bold>
    </td>
    <td style="text-align: center;" rowspan="1" colspan="1">53</td>
    <td style="text-align: center;" rowspan="1" colspan="1">47</td>
    <td style="text-align: center;" rowspan="1" colspan="1">UDCA (0.75 g/d) + Ademethionine (1.0 g/d)</td>
    <td style="text-align: center;" rowspan="1" colspan="1">Kuhuang injection (60 ml/d)</td>
    <td style="text-align: center;" rowspan="1" colspan="1">4 w</td>
    <td style="text-align: center;" rowspan="1" colspan="1">ALT, GGT, ALP, TBIL</td>
   </tr>
   <tr style="vertical-align: top;">
    <td rowspan="1" colspan="1">
     <bold>Qureshi et al. (</bold>
     <xref rid="A29052R28" ref-type="bibr">28</xref>
     <bold>)</bold>
    </td>
    <td style="text-align: center;" rowspan="1" colspan="1">18</td>
    <td style="text-align: center;" rowspan="1" colspan="1">12</td>
    <td style="text-align: center;" rowspan="1" colspan="1">UDCA (0.5 g/d)</td>
    <td style="text-align: center;" rowspan="1" colspan="1">Placebo (unclear)</td>
    <td style="text-align: center;" rowspan="1" colspan="1">12 w</td>
    <td style="text-align: center;" rowspan="1" colspan="1">ALT</td>
   </tr>
   <tr style="vertical-align: top;">
    <td rowspan="1" colspan="1">
     <bold>Ratziu et al. (</bold>
     <xref rid="A29052R29" ref-type="bibr">29</xref>
     <bold>)</bold>
    </td>
    <td style="text-align: center;" rowspan="1" colspan="1">62</td>
    <td style="text-align: center;" rowspan="1" colspan="1">64</td>
    <td style="text-align: center;" rowspan="1" colspan="1">UDCA (0.5 g/d)</td>
    <td style="text-align: center;" rowspan="1" colspan="1">Placebo (unclear)</td>
    <td style="text-align: center;" rowspan="1" colspan="1">48 w</td>
    <td style="text-align: center;" rowspan="1" colspan="1">ALT, AST, GGT, TBIL</td>
   </tr>
   <tr style="vertical-align: top;">
    <td rowspan="1" colspan="1">
     <bold>Tkacz et al. (</bold>
     <xref rid="A29052R12" ref-type="bibr">12</xref>
     <bold>)</bold>
    </td>
    <td style="text-align: center;" rowspan="1" colspan="1">45</td>
    <td style="text-align: center;" rowspan="1" colspan="1">15</td>
    <td style="text-align: center;" rowspan="1" colspan="1">Silibinin (0.42 g/d)</td>
    <td style="text-align: center;" rowspan="1" colspan="1">Placebo (unclear)</td>
    <td style="text-align: center;" rowspan="1" colspan="1">45 d</td>
    <td style="text-align: center;" rowspan="1" colspan="1">ALT, AST, TBIL</td>
   </tr>
   <tr style="vertical-align: top;">
    <td style="vertical-align: middle;" rowspan="1" colspan="1">
     <bold>Flisiak et al. (</bold>
     <xref rid="A29052R30" ref-type="bibr">30</xref>
     <bold>)</bold>
    </td>
    <td style="text-align: center;" rowspan="1" colspan="1">15</td>
    <td style="text-align: center;" rowspan="1" colspan="1">16</td>
    <td style="text-align: center;" rowspan="1" colspan="1">Misoprostol (0.8 g/d)</td>
    <td style="text-align: center;" rowspan="1" colspan="1">Silibinin (0.21 g/d)</td>
    <td style="text-align: center;" rowspan="1" colspan="1">12 w</td>
    <td style="text-align: center;" rowspan="1" colspan="1">ALT, TBIL</td>
   </tr>
   <tr style="vertical-align: top;">
    <td rowspan="1" colspan="1">
     <bold>Flisiak et al. (</bold>
     <xref rid="A29052R31" ref-type="bibr">31</xref>
     <bold>)</bold>
    </td>
    <td style="text-align: center;" rowspan="1" colspan="1">25</td>
    <td style="text-align: center;" rowspan="1" colspan="1">25</td>
    <td style="text-align: center;" rowspan="1" colspan="1">Silibinin (0.21 g/d) + misoprostol (0.8 g/d)</td>
    <td style="text-align: center;" rowspan="1" colspan="1">Placebo (unclear)</td>
    <td style="text-align: center;" rowspan="1" colspan="1">24 w</td>
    <td style="text-align: center;" rowspan="1" colspan="1">ALT, AST, GGT, TBIL</td>
   </tr>
   <tr style="vertical-align: top;">
    <td rowspan="1" colspan="1">
     <bold>Gu et al. (</bold>
     <xref rid="A29052R32" ref-type="bibr">32</xref>
     <bold>)</bold>
    </td>
    <td style="text-align: center;" rowspan="1" colspan="1">33</td>
    <td style="text-align: center;" rowspan="1" colspan="1">32</td>
    <td style="text-align: center;" rowspan="1" colspan="1">Silibinin (0.6 g/d) + oxymatrine (0.6 g/d)</td>
    <td style="text-align: center;" rowspan="1" colspan="1">Silibinin (0.6 g/d)</td>
    <td style="text-align: center;" rowspan="1" colspan="1">12 w</td>
    <td style="text-align: center;" rowspan="1" colspan="1">ALT, TBIL</td>
   </tr>
   <tr style="vertical-align: top;">
    <td rowspan="1" colspan="1">
     <bold>Bao et al. (</bold>
     <xref rid="A29052R33" ref-type="bibr">33</xref>
     <bold>)</bold>
    </td>
    <td style="text-align: center;" rowspan="1" colspan="1">42</td>
    <td style="text-align: center;" rowspan="1" colspan="1">42</td>
    <td style="text-align: center;" rowspan="1" colspan="1">Silibinin (0.36 g/d) + Interferon α-16 (300 million U, q.o.d.)</td>
    <td style="text-align: center;" rowspan="1" colspan="1">Interferon α-16 (300 million U, qod.)</td>
    <td style="text-align: center;" rowspan="1" colspan="1">12 w</td>
    <td style="text-align: center;" rowspan="1" colspan="1">ALT, AST</td>
   </tr>
   <tr style="vertical-align: top;">
    <td style="vertical-align: middle;" rowspan="1" colspan="1">
     <bold>Bao et al. (</bold>
     <xref rid="A29052R34" ref-type="bibr">34</xref>
     <bold>)</bold>
    </td>
    <td style="text-align: center;" rowspan="1" colspan="1">86</td>
    <td style="text-align: center;" rowspan="1" colspan="1">86</td>
    <td style="text-align: center;" rowspan="1" colspan="1">Silibinin (0.36 g/d) + Lamivudine (0.1 g/d)</td>
    <td style="text-align: center;" rowspan="1" colspan="1">Lamivudine (0.1 g/d)</td>
    <td style="text-align: center;" rowspan="1" colspan="1">48 w</td>
    <td style="text-align: center;" rowspan="1" colspan="1">ALT, AST, ALP, TBIL</td>
   </tr>
   <tr style="vertical-align: top;">
    <td rowspan="1" colspan="1">
     <bold>Kim et al. (</bold>
     <xref rid="A29052R35" ref-type="bibr">35</xref>
     <bold>)</bold>
    </td>
    <td style="text-align: center;" rowspan="1" colspan="1">42</td>
    <td style="text-align: center;" rowspan="1" colspan="1">43</td>
    <td style="text-align: center;" rowspan="1" colspan="1">UDCA (0.6 g/d) + Candesartan (0.008 g/d)</td>
    <td style="text-align: center;" rowspan="1" colspan="1">Candesartan (0.008 g/d)</td>
    <td style="text-align: center;" rowspan="1" colspan="1">24 w</td>
    <td style="text-align: center;" rowspan="1" colspan="1">ALT, AST, GGT, TBIL</td>
   </tr>
   <tr style="vertical-align: top;">
    <td rowspan="1" colspan="1">
     <bold>Wang et al. (</bold>
     <xref rid="A29052R36" ref-type="bibr">36</xref>
     <bold>)</bold>
    </td>
    <td style="text-align: center;" rowspan="1" colspan="1">45</td>
    <td style="text-align: center;" rowspan="1" colspan="1">44</td>
    <td style="text-align: center;" rowspan="1" colspan="1">Silibinin (0.315 g/d) + protect liver treatment + Lamivudine (0.1 g/d)</td>
    <td style="text-align: center;" rowspan="1" colspan="1">Protect liver treatment (energy mixture, inosine, salvia miltiorrhiza, promoting liver cell growth hormone and vitamin) + Lamivudine (0.1 g/d)</td>
    <td style="text-align: center;" rowspan="1" colspan="1">NA</td>
    <td style="text-align: center;" rowspan="1" colspan="1">HA, PC, CIV, LN</td>
   </tr>
   <tr style="vertical-align: top;">
    <td rowspan="1" colspan="1">
     <bold>Wu et al. (</bold>
     <xref rid="A29052R37" ref-type="bibr">37</xref>
     <bold>)</bold>
    </td>
    <td style="text-align: center;" rowspan="1" colspan="1">40</td>
    <td style="text-align: center;" rowspan="1" colspan="1">40</td>
    <td style="text-align: center;" rowspan="1" colspan="1">UDCA (13-15 mg/kg/d) + Fuzhenghuayu Capsules (4.5 g/d)</td>
    <td style="text-align: center;" rowspan="1" colspan="1">Fuzhenghuayu Capsules (4.5 g/d)</td>
    <td style="text-align: center;" rowspan="1" colspan="1">48 w</td>
    <td style="text-align: center;" rowspan="1" colspan="1">ALT, AST, GGT, TBIL, ALP, HA, LN, IVC, PIIIP</td>
   </tr>
   <tr style="vertical-align: top;">
    <td rowspan="1" colspan="1">
     <bold>Mao et al. (</bold>
     <xref rid="A29052R38" ref-type="bibr">38</xref>
     <bold>)</bold>
    </td>
    <td style="text-align: center;" rowspan="1" colspan="1">36</td>
    <td style="text-align: center;" rowspan="1" colspan="1">34</td>
    <td style="text-align: center;" rowspan="1" colspan="1">Tanshinone (0.06 g/d) + Oxymatrine (0.6 g/d)</td>
    <td style="text-align: center;" rowspan="1" colspan="1">Tanshinone (0.06 g/d)</td>
    <td style="text-align: center;" rowspan="1" colspan="1">4 w</td>
    <td style="text-align: center;" rowspan="1" colspan="1">ALT, AST, TBILI, HA, LN, PIIIP, IVC</td>
   </tr>
   <tr style="vertical-align: top;">
    <td rowspan="1" colspan="1">
     <bold>Zhou et al. (</bold>
     <xref rid="A29052R39" ref-type="bibr">39</xref>
     <bold>)</bold>
    </td>
    <td style="text-align: center;" rowspan="1" colspan="1">30</td>
    <td style="text-align: center;" rowspan="1" colspan="1">30</td>
    <td style="text-align: center;" rowspan="1" colspan="1">Valsartan (0.08 g/d) + Silibinin (0.14 g/d)</td>
    <td style="text-align: center;" rowspan="1" colspan="1">Silibinin (0.14 g/d)</td>
    <td style="text-align: center;" rowspan="1" colspan="1">12 w</td>
    <td style="text-align: center;" rowspan="1" colspan="1">HA, LN, IV-C, PIIIP</td>
   </tr>
  </tbody>
 </table>
 <table-wrap-foot>
  <fn id="fn27897">
   <p>
    <sup>a</sup> Abbreviations: ALT, Alanine aminotransferase Aminotransferase; ALP; alkaline Alkaline phosphatase Phosphatase; AST, aspartate Aspartate aminotransferase Aminotransferase; CIV collagen Collagen type IV; HA, hyaluronic Hyaluronic acid Acid; LN, laminin Laminin; PIIIP, procollagen Procollagen III peptide Peptide; TBIL, total bilirubin; γ-GGT, gamma-glutamyl Glutamyl transpeptidase Transpeptidase
   </p>
  </fn>
 </table-wrap-foot>
</table-wrap>
